Year
Edition number
№s5-17№20 (353)№19 (352)№14 (347)№18 (351)№16 (349)№15 (348)№s4-17№13 (346)№s3-17№11 (344)№12 (345)№10 (343)№КР2№9 (342)№8 (341)№КР1№7 (340)№6 (339)№5 (338)№4 (337)№s2-17№2 (335)№s1-17№3 (336)№1 (334)
№17 (350) / 2017
V.F. Semiglazov (1), V.V. Semiglazov (2), K.S. Nikolaev (1), A.V. Komyakhov (1), T.Yu. Semiglazova (1), R.M. Paltoev (1), R.V. Donskikh (1), A.I. Tseluyko (1), A.S. Artemyeva (1), V.O. Bashlyk (1), G.F. Miryusupova (3), G.A. Dashyan (1)
DE-ESCALATION AND ESCALATION OF TREATMENT OF PATIENTS WITH HER2-POSITIVE BREAST CANCER8-13
V.V. Nikoda, S.M. Kuznetsova, A.S. Prusova
CLINICAL AND MICROBIOLOGICAL FEATURES OF TEDIZOLID - NEW REPRESENTATIVE OF OXAZOLIDINONE GROUP14-23
L.G. Zhukova, E.I. Chichikov, O.O. Gordeeva, D.A. Filonenko
PALBOCICLIB – NEW POSSIBILITIES OF THERAPY OF HORMON-POSITIVE HER2-NEGATIVE BREAST CANCER24-29
M.E. Abramov, E.I. Chichikov, E.I. Borisova, S.L. Gutorov
OLAPARIB – PROMISING DIRECTION IN THERAPY IN BRCA-ASSOCIATED TUMORS30-34
F.V. Moiseenko, A.A. Kudryavtsev, A.V. Myslik, N.M. Volkov
NEW MOLECULAR SUBTYPES OF NON-SMALL CELL LUNG CANCER AND THE POSSIBILITIES OF THEIR TREATMENT35-38
E.V. Bakhidze (1, 3), A.V. Belyaeva (1, 2)
SURGICAL AND COMBINED TREATMENT OF UTERINE CARCINOSARCOMA39-44
V.F. Semiglazov, G.A. Dashyan, P.V. Krivorotko, R.M. Paltuev, R.V. Donskikh, T.Yu. Semiglazova, K.Y. Zernov, L.P. Gigolaeva, V.S. Apollonova
NEW POSSIBILITIES OF THE TREATMENT OF BREAST CANCER: MICROTUBULE INHIBITORS45-48
S.L. Plavinsky (1), P.I. Shabalkin (2)
COST-EFFECTIVENESS ANALYSIS, COST-UTILITY ANALYSIS AND INFLUENCE ON THE BUDGET OF THE RUSSIAN FEDERATION OF REPLACEMENT OF I GENERATION 5TH3 RECEPTOR ANTAGONISTS ON PALONOSETRON FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING50-54
K.V. Orlova, L.V. Demidov
OPPORTUNITIES OF COMBINED TARGETED THERAPY WITH VEMURAFENIB AND COBIMETINIB IN METASTATIC BRAF-POSITIVE CUTANEOUS MELANOMA: LONG-TERM RESULTS OF CLINICAL TRIALS55-60
N.S. Besova, E.S. Obarevich, M.M. Davydov, O.A. Beznos, N.N. Tupitsyn
PROGNOSTIC VALUES OF THE PRESENCE OF DISSEMINATED TUMOR CELLS IN THE BONE MARROW IN PATIENTS WITH DISSEMINATED STOMACH CANCER BEFORE START OF TREATMENT WITH ANTITUMOR DRUGS62-66
Yu.Yu. Sergeev (1, 3), V.V. Mordovtseva (2), V.Yu. Sergeev (3)
SKIN MELANOMA IN PRACTICE OF DERMATOLOGIST67-72
A.D. Kaprin, A.A. Kostin, N.V. Vorobyev, S.V. Popov
MODERN APPROACHES TO THE DIAGNOSIS AND TREATMENT OF ACUTE PYELONEPHRITIS IN PATIENTS WITH BLADDER CANCER74-77
F.A. Abbasov, M.A. Anikina, O.S. Zimnyakova, A.A. Davtyan, E.V. Bril
CHEMOTHERAPY-ASSOCIATED POLYNEUROPATHY: PROBLEMS AND OBJECTS AT THE CURRENT STAGE OF NEUROLOGICAL ASSISTANCE TO ONCOLOGICAL PATIENTS78-82
N.S. Besova, E.S. Obarevich, O.A. Beznos, N.N. Tupitsyn, M.M. Davydov
PROGNOSTIC VALUE OF THE DYNAMICS OF DISSEMINATED TUMOR CELLS IN THE BONE MARROW IN PATIENTS WITH DISSEMINATED ADENOCARCINOMA OF THE STOMACH OR THE ESOPHAGOGASTRIC JUNCTION83-86
N.S. Besova, E.V. Trusilova, E.S. Obarevich, N.N. Tupitsin, V.A. Gorbunova, M.M. Davydov, N.Ts. Drobot, B.A. Perfiliev, O.A. Malikhova
EXAMPLE OF THE INTEGRATED APPROACH TO TREATMENT OF THE PATIENT WITH DISSEMINATED STOMACH CANCER TAKING INTO ACCOUNT OF MODERN CLINICAL TRENDS87-91
G.A. Khakimov (1), Sh.V. Ziyaev (1), Sh.Sh. Kadyrov (1), G.G. Khakimova (2), D.R. Dyakina (1), I.A. Tursunkulov (3), S.D. Bezhanova (2)
CASUISTIC CASE OF SYNOVIAL SARCOMA OF THE GASTROINTESTINAL TRACT92-95
